Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Part I (SAD) - Healthy Participants”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)Study completedNCT02307162
What this trial is testing

SAD/MAD Study of a New Formulation of Nebulised RPL554 in Healthy Subjects and COPD Subjects

Who this might be right for
Inflammatory Disorder of the Respiratory TractChronic Obstructive Pulmonary Disorder
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 112
Early research (Phase 1)Looking for participantsNCT07630545
What this trial is testing

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

Who this might be right for
Parkinson's Disease (PD)Mild to Moderate Parkinson's DiseaseEarly Stage Parkinson's Disease
Mission Therapeutics 106
Early research (Phase 1)Study completedNCT03096795
What this trial is testing

Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese Participants

Who this might be right for
Part I (SAD) - Healthy ParticipantsPart II (MAD) - Chronic Obstructive Pulmonary DiseasePart III (J-SD) - Healthy Japanese Participants
MedImmune LLC 88